SOURCE: DATATRAK International , Inc.

DATATRAK International , Inc.

November 16, 2015 08:00 ET

DATATRAK Announces the Appointment of New Independent Director

Company Fills Vacancy in Class II of the Board of Directors With Appointment of Andrew Pitler as Independent Director

CLEVELAND, OH--(Marketwired - November 16, 2015) - DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical technologies and delivering related services for the clinical trials industry, today announced that it has filled the existing vacancy in Class II of the Board of Directors and added a new independent member to its Board with the appointment of Andrew Thomas Pitler as an independent director. Mr. Pitler's appointment was effective at the conclusion of the regularly scheduled Board of Directors meeting on November 11, 2015.

As previously disclosed, the Company's Board size has been set at six directors for some time, with five current Board members and one vacancy in Class II. Thus, no further addition to the Board size was required to fill the existing vacancy. The Company identified Mr. Pitler through its process of outreach with shareholders, including input from its independent strategic Human Resource advisor. After thorough evaluation of candidate qualifications in light of the Board's criteria, the Board recommended the appointment of Mr. Pitler as an independent director. Mr. Pitler's interests are directly aligned with shareholders, as he has been a significant shareholder of DATATRAK since 2010 and is currently the beneficial owner of 2.9% of DATATRAK shares. With this new appointment, DATATRAK will have five independent directors on its Board.

"Mr. Pitler is an experienced leader in the health care business community and brings significant talent and expertise to the Board table. We are excited to welcome him to the DATATRAK Board of Directors," said Chairman and CEO, Laurence P. Birch. "The Board's Nominating and Corporate Governance Committee (which is comprised of three independent Directors) has been conducting a thorough search to fill this role for over a year to complement the highly skilled, highly qualified, independent Directors that we are fortunate to have managing the welfare of our Company -- and Mr. Pitler certainly fills those requirements," Birch concluded.

Mr. Pitler joins DATATRAK with significant health care industry experience. Prior to his retirement in December 2013, he was the Vice President of Sales for Health Integrated, Inc. for seven years. Health Integrated provides a variety of integrated general and behavioral health services to health and insurance markets. From 1999 to 2006, Mr. Pitler held a variety of senior management positions with Neoforma, Inc. who designed, sold and deployed online contract and purchasing services for hospitals and their medical/surgical suppliers. Mr. Pitler has been a member of the Board of Directors of two private companies and has strong working knowledge of the challenges and needs of small health care companies.

"I am delighted to be joining the Board of DATATRAK," said Mr. Pitler. "The health care industry is going through a period of transformation as it adapts to this new digital world. In the clinical trial space companies are looking for solution providers that help simplify the research process and reduce complexities. The DATATRAK team has positioned the Company well to capitalize on these opportunities through the execution of its strategy. I look forward to contributing to the advancement of the organization for the benefit of customers, shareholders and employees."

DATATRAK International is a worldwide technology and services Company delivering Unified dClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Chicago, IL; Cary Research Triangle Park (RTP), North Carolina; Bryan, Texas; and Cleveland, Ohio. For more information, visit

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 13, 2015 announcing its results for the full year period ended December 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

Contact Information

  • Investor Relations Contact:
    Monica Gupta or Nick Hughes
    Alpha IR Group